Collectively, our immunohistochemical characterization of the SIRS mouse model leads us to propose that RIPK3 is regulated akin to a positive acute phase reactant, with hepatic and intestinal expression that rapidly increases in response to inflammation. This evidence concerns the gene RIPK3 and systemic inflammatory response syndrome.